Health Condition 1: N939- Abnormal uterine and vaginal bleeding, unspecified
Conditions
Interventions
Intervention1: ERAS Protocol: Pre-emptive analgesia (preoperatively) in form of Gabapentin and rectal suppository (diclofenac sodium).
Local infilteration with Local anaesthetic (5ml 0.25% bupivacaine
Sponsors
Dr Roshni Panwar
Eligibility
Inclusion criteria
Inclusion criteria: Patients of ASA grade I and II scheduled for abdominal hysterectomy
Exclusion criteria
Exclusion criteria: Patients with pre-existing cardiac disease, diabetes, autoimmune disorder, severe/uncontrolled hypertension, severe/uncontrolled asthma, uncontrolled hypo/hyper thyroidism, severe renal/ hepatic dysfunction, neurological/ psychiatric illness, patient refusal and any contraindication for spinal anaesthesia.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate the efficacy of implementaion of predefined ERAS protocol on postoperative pain assessment, length of hospital stay and quality of recovery.Timepoint: From day of admission to day of discharge. | — |
Secondary
| Measure | Time frame |
|---|---|
| To compare ERAS protocol with traditional protocol in terms of Quality of recovery, Readiness of discharge, adverse effects and to analyse the barriers to implementationn of ERAS protocolTimepoint: From day of admission to day of discharge. | — |
Countries
India
Contacts
Public ContactDr Savita Choudhary
Geetanjali Medical College and Hospital
Outcome results
None listed